D.B. Root & Company’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,598
Closed -$205K 169
2022
Q4
$205K Sell
1,598
-98
-6% -$12.6K 0.09% 156
2022
Q3
$232K Buy
1,696
+6
+0.4% +$977 0.11% 147
2022
Q2
$299K Sell
1,690
-2,465
-59% -$355K 0.13% 144
2022
Q1
$598K Buy
4,155
+36
+0.9% +$4.87K 0.22% 109
2021
Q4
$636K Sell
4,119
-93
-2% -$15.6K 0.23% 110
2021
Q3
$715K Sell
4,212
-841
-17% -$131K 0.28% 100
2021
Q2
$797K Sell
5,053
-49
-1% -$7.28K 0.3% 91
2021
Q1
$708K Buy
+5,102
New +$822K 0.28% 95
2020
Q1
Sell
-2,843
Closed -$324K 208
2019
Q4
$324K Sell
2,843
-92
-3% -$9.76K 0.14% 164
2019
Q3
$250K Sell
2,935
-2,630
-47% -$193K 0.12% 173
2019
Q2
$385K Buy
5,565
+2,245
+68% +$157K 0.17% 139
2019
Q1
$243K Sell
3,320
-4,560
-58% -$324K 0.1% 186
2018
Q4
$446K Buy
7,880
+1,195
+18% +$75K 0.22% 115
2018
Q3
$516K Sell
6,685
-1,295
-16% -$95.4K 0.23% 123
2018
Q2
$530K Sell
7,980
-1,575
-16% -$90.2K 0.25% 128
2018
Q1
$500K Buy
+9,555
New +$521K 0.26% 119

Other funds holding SGEN

D.B. Root & Company's SGEN Position: Q1 2023 in Review

D.B. Root & Company sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 1,598 shares — an estimated $205K sold.

D.B. Root & Company first reported a position in SGEN in Q1 2018 and held it in 16 quarters. The position peaked at $797K in Q2 2021. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • D.B. Root & Company reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • D.B. Root & Company sold 1,598 Seagen Inc. Common Stock shares in Q1 2023, an estimated $205K.
  • D.B. Root & Company first reported a position in Seagen Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • D.B. Root & Company's Seagen Inc. Common Stock position peaked at $797K in Q2 2021.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on D.B. Root & Company's 13F filing for Q1 2023, filed 18 Apr 2023.